KR20040019569A - A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof - Google Patents
A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof Download PDFInfo
- Publication number
- KR20040019569A KR20040019569A KR1020020051155A KR20020051155A KR20040019569A KR 20040019569 A KR20040019569 A KR 20040019569A KR 1020020051155 A KR1020020051155 A KR 1020020051155A KR 20020051155 A KR20020051155 A KR 20020051155A KR 20040019569 A KR20040019569 A KR 20040019569A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- medical device
- surfactant
- acid
- disinfecting
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/722—Ethers of polyoxyalkylene glycols having mixed oxyalkylene groups; Polyalkoxylated fatty alcohols or polyalkoxylated alkylaryl alcohols with mixed oxyalkylele groups
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/02—Inorganic compounds ; Elemental compounds
- C11D3/04—Water-soluble compounds
- C11D3/042—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
- A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
- A61L2/18—Liquid substances or solutions comprising solids or dissolved gases
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/20—Organic compounds containing oxygen
- C11D3/2075—Carboxylic acids-salts thereof
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/36—Organic compounds containing phosphorus
- C11D3/361—Phosphonates, phosphinates or phosphonites
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/16—Organic compounds
- C11D3/37—Polymers
- C11D3/3703—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- C11D3/3707—Polyethers, e.g. polyalkyleneoxides
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3942—Inorganic per-compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3945—Organic per-compounds
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/39—Organic or inorganic per-compounds
- C11D3/3947—Liquid compositions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Detergent Compositions (AREA)
- External Artificial Organs (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
Abstract
Description
본 발명은 양쪽 말단에 알콜성 기를 갖는 계면활성제를 포함하는 과초산계 의료기기 소독 세척제 및 그의 제조방법에 관한 것이다.The present invention relates to a peracetic acid type medical device disinfecting cleaning agent comprising a surfactant having an alcoholic group at both ends, and a method of manufacturing the same.
국내의 병원에서는 하루 2회 또는 3회의 투석을 실시하기 때문에 장치의 소독과 세척의 시간이 짧고, 오염의 가능성이 매우 높은 실정이다. 특히, 국내에 가장 많이 보급되어진 혈액투석장치의 경우, 사용량이 계속 증가하고 있는 글루코즈가 함유된 투석액을 사용하므로 기기내에 장착되어 있는 특수 센서가 오염되는 경우가 많아 기기의 유지 보수에 많은 어려움을 가지고 있었다.Since domestic hospitals perform dialysis twice or three times a day, the time for disinfection and cleaning of the device is short, and the possibility of contamination is very high. In particular, in the case of hemodialysis devices that are most widely used in Korea, the use of glucose-containing dialysis fluid is continuously increasing, so that the special sensors installed in the device are often contaminated, which makes it difficult to maintain the device. there was.
각종 혈액투석장치와 그 배관 내부에 생성된 스케일의 제거 및 바이오 필름 등의 박리를 위한 소독 세척제의 사용은 필수적이다. 현재 이를 위한 소독 세척제로 일반적으로 차아염소산 나트륨을 주로 사용하고, 주 1∼2회 정도 구연산이나 포르말린 또는 초산 등을 추가로 사용하고 있다. 그러나, 차아염소산 나트륨과 초산은 어느 정도의 살균력과 스케일 제거력을 가지고 있긴 하지만, 스케일 제거를 목적으로 사용된 고농도의 초산은 차아염소산 나트륨과 함께 기기 부식의 주된 원인이 된다. 또한, 이 부식으로 인하여 기기의 잦은 고장이 발생하고, 그 결과 의료기기의 수명을 단축시키는 원인이 된다. 더욱이, 시간, 전기, 물의 낭비는 물론 포르말린과 차아염소산 나트륨에 의해 2차 환경오염을 발생시키는 문제점도 발생하게 된다. 또한, 투석장치 배관 내의 스케일, 바이오 필름 및 세균 포자 등을 제거할 수 없는 문제점도 여전히 남아 있게 되어, 소독 및 세척이 완전히 이루어지지 않는 단점이 있다.It is essential to use a disinfecting detergent for removing various hemodialysis apparatuses and scales generated inside the pipes and for peeling off biofilms. Currently, sodium hypochlorite is mainly used as a disinfectant cleaner for this purpose, and additionally citric acid, formalin or acetic acid is used once or twice a week. However, although sodium hypochlorite and acetic acid have some degree of bactericidal and descaling power, the high concentration of acetic acid used for descaling together with sodium hypochlorite is a major cause of instrument corrosion. In addition, the corrosion causes frequent breakdowns of the device, which results in shortening the life of the medical device. Moreover, not only waste of time, electricity and water, but also a problem of generating secondary environmental pollution by formalin and sodium hypochlorite occurs. In addition, there is still a problem that can not remove the scale, biofilm and bacterial spores, etc. in the dialysis apparatus pipe, there is a disadvantage that disinfection and cleaning is not completely made.
한편, 상기한 문제점을 해결하기 위한 새로운 세척제로서 과초산계 의료기기 소독 세척제가 개발된 바 있다 (국제특허공개 제WO 88/08667호, 국제특허공개 제WO 93/07909호, 국제특허공개 제WO 94/14321호, 유럽특허공개 제EP 193,426호, 유럽특허공개 제EP 596493호, 미국특허 제US 6168,808호, 한국특허공개 제2000-49667호 등).Meanwhile, a peracetic acid-based medical device disinfectant cleaner has been developed as a new detergent to solve the above problems (WO 88/08667, WO 93/07909, WO WO). 94/14321, European Patent Publication No. EP 193,426, European Patent Publication No. EP 596493, US Patent No. US 6168,808, Korean Patent Publication No. 2000-49667, and the like.
상기한 종래의 과초산계 의료기기 소독 세척제들은 과초산, 초산, 과산화수소, 및 정제수를 함유하며, 인산, 포스폰산 등의 안정화제, 소르비탄 모노팔미테이트, 폴리옥시에틸렌 세틸 에테르 등의 비이온성 계면활성제, 또는 아민옥사이드류(amine oxides) 등을 포함하고 있다.The conventional peracetic acid-based medical device disinfectant cleaners contain peracetic acid, acetic acid, hydrogen peroxide, and purified water, and nonionic interfaces such as stabilizers such as phosphoric acid and phosphonic acid, sorbitan monopalmitate, and polyoxyethylene cetyl ether. Active agents, or amine oxides.
그러나, 상기와 같은 종래의 과초산계 의료기기 소독 세척제에 소르비탄 모노팔미테이트, 폴리옥시에틸렌 세틸 에테르 등을 사용하는 경우, 기포 발생을 충분히 억제하지 못하기 때문에 기포가 발생하게 되며, 기포가 발생한 경우 소독제와의료기기와의 접촉을 방해함으로써 충분한 소독이 이루어지지 않는 문제점이 있다.However, when sorbitan monopalmitate, polyoxyethylene cetyl ether, or the like is used in the conventional peracetic acid medical device disinfecting detergent, bubbles are generated because bubbles are not sufficiently suppressed, and bubbles are generated. In this case, there is a problem that sufficient disinfection is not achieved by preventing contact between the disinfectant and the medical device.
이에, 본 발명자들은 이러한 기포 발생으로 인한 단점을 방지하기 위하여 연구를 거듭한 결과, 과초산계 소독 세척제에 양쪽 말단에 알콜성 기를 갖는 계면활성제를 첨가하여 사용할 경우, 사용시 기포발생이 전혀 없어 종래의 소독 세척제에 있어서의 기포 발생으로 인한 문제점을 해결할 수 있음을 발견하여 본 발명을 완성하기에 이르렀다.Therefore, the present inventors have conducted a study to prevent the disadvantages caused by the bubble generation, as a result, when used with a surfactant having an alcoholic group at both ends to the peracetic acid disinfecting detergent, there is no bubble during use at all The present invention has been completed by discovering that problems caused by bubble generation in a disinfectant cleaner can be solved.
따라서, 본 발명은 세척력 및 살균력을 유지하면서도 기포 발생의 문제점이 없는 특정 계면활성제를 포함하는 의료기기 소독 세척제를 제공하는 것을 목적으로 한다.Accordingly, an object of the present invention is to provide a medical device disinfecting cleaning agent containing a specific surfactant that does not have the problem of bubble generation while maintaining the cleaning and sterilizing power.
또한, 본 발명의 목적은 상기 의료기기 소독 세척제를 제조하는 방법을 제공하는 것을 포함한다.It is also an object of the present invention to provide a method for producing the medical device disinfectant cleaner.
본 발명의 의료기기 소독 세척제는 과초산 1.0∼1.6 중량%, 초산 0.1∼20 중량%, 과산화수소 1∼6 중량%, 인산 0.1∼20 중량%, 1,1-디포스폰산 0.1∼5 중량%, 및 하기 화학식 1의 구조를 갖는 적어도 1개의 계면활성제 0.001∼10 중량%를 포함하고, 나머지는 정제수, 역삼투압수, 또는 탈이온화 정제수로 이루어진 소독 세척제이다.Medical device disinfectant cleaning agent of the present invention 1.0 to 1.6% by weight peracetic acid, 0.1 to 20% by weight acetic acid, 1 to 6% by weight hydrogen peroxide, 0.1 to 20% by weight phosphoric acid, 0.1 to 5% by weight 1,1-diphosphonic acid, And 0.001 to 10% by weight of at least one surfactant having a structure of formula (1), the remainder is a disinfecting detergent consisting of purified water, reverse osmosis water, or deionized purified water.
상기 식에서, l, m, 및 n은 각각 1∼50의 정수로서, l 및 n의 합은 2∼50이다.Wherein l, m and n are each an integer of 1 to 50, and the sum of l and n is 2 to 50.
상기 과초산 및 과산화 수소는 본 발명의 소독 세척제가 가지는 기능인 살균 기능에 직접적으로 관여하는 성분으로서, 이들 각 성분은 본 발명의 소독 세척제에서 평형상태로 존재하게 된다.The peracetic acid and hydrogen peroxide are components directly involved in the sterilization function which is a function of the disinfectant cleaner of the present invention, and each of these components will exist in an equilibrium state in the disinfectant cleaner of the present invention.
상기 인산(phosphoric acid) 및 1,1-디포스폰산(1,1-diphosphonic acid)은 혼합 안정화제로서, 각각의 구조는 다음과 같다.The phosphoric acid (phosphoric acid) and 1,1-diphosphonic acid (1,1-diphosphonic acid) is a mixed stabilizer, each structure is as follows.
이러한, 인산 및 1,1-디포스폰산은 본 발명의 소독 세척제에서 상기한 과초산 및 과산화수소를 안정화시키는 역할 외에 탄산칼슘, 칼슘 설페이트 등의 스케일 제거력을 향상시키는 효과를 가지고 있다. 또한, 본 발명의 소독 세척제는 안정화제로서 인산을 혼합사용함으로써 탄산칼슘, 탄산칼륨 등의 스케일을 효과적으로 제거하기 위한 산성의 산도를 부여한다. 따라서, 본 발명에서 사용한 혼합안정화제는 안정화제로서의 효과 뿐 아니라 소독 세척제의 산도를 바람직한 범위로 제조할 수 있도록 한다.Such, phosphoric acid and 1,1-diphosphonic acid has the effect of improving the scale removal ability of calcium carbonate, calcium sulfate, etc. in addition to stabilizing the peracetic acid and hydrogen peroxide in the disinfecting cleaning agent of the present invention. In addition, the disinfectant cleaning agent of the present invention gives an acidity for removing the scale of calcium carbonate, potassium carbonate and the like effectively by mixing phosphoric acid as a stabilizer. Therefore, the mixed stabilizer used in the present invention enables to prepare not only the effect as a stabilizer but also the acidity of the disinfectant cleaning agent in a preferable range.
또한, 본 발명에서 특징적으로 사용하는 계면활성제는 다음 화학식 1의 구조를 가지는 것이면 어느 것이나 이용될 수 있다.In addition, any surfactant that is characteristically used in the present invention may be used as long as it has the structure of Formula 1.
1One
(상기 식에서, l, m, 및 n은 각각 1∼50의 정수로서, l 및 n의 합은 2∼50이다.)(Wherein l, m, and n are each an integer of 1 to 50, and the sum of l and n is 2 to 50).
상기 계면활성제는 바람직하기로는, l+n 즉, 에틸렌옥사이드 부위의 함량이 약 4∼50 몰이고, m 즉, 프로필렌 옥사이드 부위의 함량이 약 5∼40 몰인 것이다. 또한, 상기 계면활성제의 분자량은 1500∼3000 이 바람직하며, 약 2,500인 것이 더욱 바람직하다. 또한, 본 발명에 사용가능한 계면활성제로는 상기 요건을 갖는 상업적으로 판매되는 계면활성제, 예를 들면, 상품명 Koremul-PE62(한농화성) 등의 폴리옥시에틸렌 및 옥시프로필렌 블록 공중합체를 사용할 수도 있다.Preferably, the surfactant is l + n, that is, the content of the ethylene oxide moiety is about 4 to 50 moles, and m, that is, the content of the propylene oxide moiety is about 5 to 40 moles. In addition, the molecular weight of the surfactant is preferably 1500 to 3000, more preferably about 2,500. In addition, as the surfactant usable in the present invention, commercially available surfactants having the above requirements, for example, polyoxyethylene and oxypropylene block copolymers such as the brand name Koremul-PE62 (ultra-concentrated) may be used.
본 발명의 소독 세척제에서 특징적으로 사용하는 상기 계면활성제는 의료기기 세척시 낮은 표면장력과 발생되는 기포가 적으므로, 소포제 등을 사용함으로써 발생하는 종래의 의료기기 세척제의 문제점을 효과적으로 해결할 수 있다. 즉, 종래의 소독 세척제는 기포를 억제하기 위하여 소포제 등을 사용함으로써, 혈액투석장치의 소독 및 세척시 엔도톡신 필터를 손상시키는 문제를 발생시키는 원인이 되었으나, 본 발명의 소독 세척제는 이러한 문제점을 발생시키지 않는다.The surfactant used in the disinfectant cleaning agent of the present invention has a low surface tension and less bubbles generated when cleaning the medical device, thereby effectively solving the problems of the conventional medical device cleaning agent generated by using an antifoaming agent or the like. That is, the conventional disinfectant cleaners are used to cause the problem of damaging the endotoxin filter during the disinfection and cleaning of the hemodialysis apparatus by using an antifoaming agent to suppress bubbles, the disinfectant cleaner of the present invention does not cause such problems Do not.
본 발명의 의료기기 소독 세척제는 용매로서 물을 사용할 수 있으며, 순수에 가깝고 오염되지 않은 정제수가 바람직하며, 역삼투압수 또는 탈이온화 증류수 등이 더욱 바람직하다.The medical device disinfectant cleaning agent of the present invention may use water as a solvent, preferably purified water that is close to pure water and uncontaminated, and more preferably reverse osmosis water or deionized distilled water.
본 발명의 의료기기 소독 세척제중에 함유되는 모든 성분들의 함량은 평형상태를 이루고 있는 최종 소독 세척제중의 함량을 나타내는 것이다.The content of all components contained in the medical device disinfecting detergent of the present invention indicates the content of the final disinfecting detergent in equilibrium.
즉, 평형상태를 이루고 있는 소독 세척제중 과초산은 1.0∼1.6 중량%, 초산은 0.1∼20 중량%, 및 과산화수소는 1∼6 중량%의 함량이 바람직하다. 물론, 이들 함량은 충분한 세척력 및 살균력을 목적으로 상기 범위를 약간씩 벗어날 수 있으나, 이는 본 발명의 의료기기 소독 세척제의 범위에 포함되는 것으로 해석되어야 한다.That is, the content of 1.0 to 1.6% by weight of peracetic acid, 0.1 to 20% by weight of acetic acid, and 1 to 6% by weight of hydrogen peroxide in the disinfecting detergent in equilibrium. Of course, these contents may deviate slightly from the above range for the purpose of sufficient detergency and sterilization power, but it should be interpreted as being included in the scope of the medical device disinfecting detergent of the present invention.
또한, 안정화제 및 스케일 제거제로서 함유되는 인산 및 1,1-디포스폰산은 각각 0.1∼20 중량% 및 0.1∼5 중량%으로 함유되는 것이 바람직하다. 물론, 이들 함량도 충분한 안정화 및 스케일 제거효과를 목적으로 상기 범위를 약간씩 벗어날 수 있으나, 이는 본 발명의 의료기기 소독 세척제의 범위에 포함되는 것으로 해석되어야 한다.In addition, it is preferable that phosphoric acid and 1,1-diphosphonic acid contained as a stabilizer and a descaling agent are contained in 0.1-20 weight% and 0.1-5 weight%, respectively. Of course, these contents may also slightly out of the above range for the purpose of sufficient stabilization and descaling effect, it should be construed to fall within the scope of the medical device disinfecting cleaning agent of the present invention.
본 발명에서 특징적으로 함유되는 화학식 1의 구조를 갖는 계면활성제의 함량으로는 0.001∼10 중량%가 바람직하며, 0.5∼5 중량%가 더욱 바람직하다.As content of surfactant which has the structure of Formula (1) characteristically contained in this invention, 0.001-10 weight% is preferable, and 0.5-5 weight% is more preferable.
본 발명의 소독 세척제에 용매 또는 희석제로 사용되는 정제수, 역삼투압수, 또는 탈이온화 정제수 등의 함량은 최종 조성물에서 상기 성분의 함량을 충족시키고 남은 양을 100%로 맞추기에 적당한 양으로 사용한다.The content of purified water, reverse osmosis water, or deionized purified water used as a solvent or diluent in the disinfectant cleaner of the present invention is used in an amount suitable to satisfy the content of the above components in the final composition and to adjust the remaining amount to 100%.
본 발명의 의료기기 소독 세척제를 사용하여 소독 및 세척을 할 수 있는 의료기기에는 특별한 제한은 없으나, 혈액투석시 발생되는 유기물 및 스케일의 제거에 탁월한 효능이 있으므로 혈액투석장치 또는 그 주변기기 장치에 사용하는 것이바람직하다.There is no particular limitation on a medical device capable of disinfection and cleaning using the medical device disinfecting cleaning agent of the present invention, but since it has an excellent effect on the removal of organic substances and scale generated during hemodialysis, it is used in a hemodialysis device or a peripheral device thereof. It is desirable.
본 발명은 상기 의료기기 소독 세척제의 제조방법을 포함한다.The present invention includes a method for producing the medical device disinfectant cleaner.
즉, 본 발명은 정제수, 더욱 바람직하게는 역삼투압수 또는 탈이온화 정제수, 50∼55 중량%와 인산 및 1,1-디포스폰산을 각각 0.1∼10 중량%, 0.1∼1.0 중량% 혼합하는 단계;That is, the present invention is a step of mixing purified water, more preferably reverse osmosis water or deionized purified water, 50 to 55% by weight and phosphoric acid and 1,1-diphosphonic acid, respectively 0.1 to 10% by weight, 0.1 to 1.0% by weight ;
초산 15∼25 중량%를 혼합하는 단계;Mixing 15-25% by weight acetic acid;
과산화수소 15∼20 중량%를 혼합하여 과초산을 형성하는 단계;Mixing 15-20 wt% hydrogen peroxide to form peracetic acid;
상기 혼합물을 35∼45℃에서 4∼7시간동안 보온한 다음, 상온에서 숙성시키는 단계; 및Incubating the mixture at 35 to 45 ° C. for 4 to 7 hours and then aging at room temperature; And
화학식 1의 구조를 갖는 적어도 1개의 계면활성제 0.001∼10 중량%를 혼합하는 단계를 포함하는 의료기기 소독 세척제의 제조방법을 포함한다.It includes a method for producing a medical device disinfecting cleaning agent comprising the step of mixing at least 0.001 to 10% by weight of at least one surfactant having a structure of formula (1).
상기 제조방법에서 보온단계는 과산화수소 및 초산의 반응을 촉진하기 위한 것이며, 숙성단계는 과산화수소의 함량을 적절한 수준으로, 예를들어 6 중량% 이하로 조정하는 단계로서 약 3일간 숙성시키는 것이 바람직하다.In the preparation method, the warming step is for promoting the reaction of hydrogen peroxide and acetic acid, and the aging step is preferably a step of adjusting the content of hydrogen peroxide to an appropriate level, for example, 6 wt% or less, for about three days.
상기 의료기기 소독 세척제는, 필요에 따라 희석제로 적절히(예를들어, 1/10∼1/50) 희석하여, 혈액투석장치 또는 그 주변기기 등의 의료기기를 효과적으로 소독 세척할 수 있다. 희석제로는 수성 용매, 바람직하기로는 정제수, 역삼투압수, 탈이온화 정제수 등이 바람직하다.The medical device disinfectant cleaning agent may be diluted with a diluent appropriately (for example, 1/10 to 1/50) as necessary to effectively disinfect and wash medical devices such as a hemodialysis device or a peripheral device thereof. As a diluent, an aqueous solvent, Preferably purified water, reverse osmosis water, deionized purified water, etc. are preferable.
이하 본 발명을 실시예를 통하여 보다 구체적으로 설명한다. 그러나, 이들 실시예는 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, these Examples are intended to illustrate the present invention more specifically, but the scope of the present invention is not limited to these Examples.
실시예 1: 본 발명의 의료기기 소독 세척제의 제조예Example 1 Preparation Example of Medical Device Disinfecting Cleanser of the Present Invention
역삼투압수 50g과 인산 및 1,1-디포스폰산을 각각 10g, 1g을 혼합한 다음, 초산 20g을 혼합하였다. 여기에 과산화수소 17g를 혼합하여 과초산을 형성시키고, 35∼45℃에서 7시간동안 보온하였다. 이를 상온에서 교반하여 숙성시킨 다음, Koremul-PE62(한농화성)의 폴리옥시에틸렌 및 옥시프로필렌 블록 공중합체 2g을 가하여 의료기기 소독 세척제를 제조하였다. 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 1.67% 및 5.78% 였다.50 g of reverse osmosis water, 10 g and 1 g of phosphoric acid and 1,1-diphosphonic acid were mixed, followed by 20 g of acetic acid. 17 g of hydrogen peroxide was mixed thereto to form peracetic acid, and kept at 35 to 45 ° C. for 7 hours. Aged by stirring at room temperature, and then 2 g of polyoxyethylene and oxypropylene block copolymer of Koremul-PE62 (concentrated) were added to prepare a disinfectant cleaner for medical devices. The concentrations of peracetic acid and hydrogen peroxide in the obtained disinfecting detergents were 1.67% and 5.78%, respectively.
실시예 2: 본 발명의 의료기기 소독 세척제의 제조예Example 2: Preparation of Medical Device Disinfecting Cleanser of the Present Invention
인산 5g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 1.08% 및 5.96% 였다.A medical device disinfectant cleaner was prepared in the same manner as in Example 1 except that 5 g of phosphoric acid was used, and the concentrations of peracetic acid and hydrogen peroxide in the disinfectant cleaners obtained were 1.08% and 5.96%, respectively.
실시예 3: 본 발명의 의료기기 소독 세척제의 제조예Example 3: Preparation of Medical Device Disinfecting Cleanser of the Present Invention
인산 5g 및 1,1-디포스폰산을 각각 0.5g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 1.30% 및 5.86% 였다.Medical device disinfectant cleaners were prepared in the same manner as in Example 1 except that 5 g of phosphoric acid and 0.5 g of 1,1-diphosphonic acid were used, respectively, and the concentrations of peracetic acid and hydrogen peroxide in the disinfectant cleaners obtained were 1.30% and 5.86%.
실시예 4: 본 발명의 의료기기 소독 세척제의 제조예Example 4 Preparation of Medical Device Disinfecting Cleanser of the Present Invention
초산 15g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 1.01% 및 5.86% 였다.A medical device disinfectant cleaner was prepared in the same manner as in Example 1 except that 15 g of acetic acid was used, and the concentrations of peracetic acid and hydrogen peroxide were 1.01% and 5.86%, respectively.
실시예 5: 본 발명의 의료기기 소독 세척제의 제조예Example 5 Preparation of Medical Device Disinfecting Cleanser of the Present Invention
초산 10g을 사용한 것을 제외하고는 실시예 1과 동일한 방법으로 의료기기 소독 세척제를 제조하였으며, 얻어진 소독 세척제중 과초산 및 과산화수소의 농도는 각각 1.01% 및 5.94% 였다.Except that 10g of acetic acid was used to prepare a medical device disinfecting detergent in the same manner as in Example 1, the concentration of peracetic acid and hydrogen peroxide in the obtained disinfecting detergent was 1.01% and 5.94%, respectively.
실시예6 : 본 발명의 소독 세척제의 사용예Example 6 Use of the Disinfecting Cleanser of the Present Invention
실시예 1에서 제조한 세척제를 사용하여 하기 표1에 기재된 방법으로 세척하였다. 즉, 갬브로사 AK200Ultra 등의 혈액투석장치를 약 2개월간 사용하면서, 하기 조건으로 소독 및 세척을 하였다.It was washed by the method described in Table 1 using the cleaning agent prepared in Example 1. That is, while using hemodialysis apparatus such as Gambrosa AK200Ultra for about 2 months, it was disinfected and washed under the following conditions.
* Set : 임의로 조정* Set: arbitrarily adjusted
ON : 하루밤 (over-night)ON: over-night
상기와 같이 소독 세척제를 사용한 결과, 현재 상업적으로 사용중인 혈액투석장치 대부분을 기포의 발생 및 엔도톡신 필터의 수명단축 없이 효과적으로 소독 및 세척을 할 수 있었다.As a result of using the disinfectant cleaner as described above, most of the hemodialysis apparatus currently in use was able to be effectively disinfected and washed without the generation of bubbles and shortening the life of the endotoxin filter.
본 발명의 의료기기 소독 세척제에 의하면, 소포제 등을 사용하지 않고 혈액투석장치 또는 그 주변 기기 장치를 소독 세척할 수 있어, 혈액투석장치의 소독 세척시 소포제 등으로 인한 엔도톡신 필터의 막힘과 같은 기능 손상을 예방할 수 있다.According to the medical device disinfecting cleaning agent of the present invention, it is possible to disinfect and clean the hemodialysis device or its peripheral device without using an antifoaming agent. Can be prevented.
Claims (5)
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0051155A KR100515929B1 (en) | 2002-08-28 | 2002-08-28 | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2 |
AU2003253480A AU2003253480A1 (en) | 2002-08-28 | 2003-08-28 | A composition for disinfecting or washing medical instruments and a process for the preparation thereof |
PCT/KR2003/001741 WO2004020561A1 (en) | 2002-08-28 | 2003-08-28 | A composition for disinfecting or washing medical instruments and a process for the preparation thereof |
JP2004532431A JP2005537355A (en) | 2002-08-28 | 2003-08-28 | Medical device disinfecting or cleaning composition and method for producing the same |
CNB03824750XA CN1297645C (en) | 2002-08-28 | 2003-08-28 | A composition for disinfecting or washing medical instruments and a process for the preparation thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2002-0051155A KR100515929B1 (en) | 2002-08-28 | 2002-08-28 | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20040019569A true KR20040019569A (en) | 2004-03-06 |
KR100515929B1 KR100515929B1 (en) | 2005-09-20 |
Family
ID=31973553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2002-0051155A KR100515929B1 (en) | 2002-08-28 | 2002-08-28 | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2 |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2005537355A (en) |
KR (1) | KR100515929B1 (en) |
CN (1) | CN1297645C (en) |
AU (1) | AU2003253480A1 (en) |
WO (1) | WO2004020561A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4834307B2 (en) * | 2005-01-14 | 2011-12-14 | 横浜油脂工業株式会社 | Disinfecting and cleaning composition comprising peracetic acid and a nonionic surfactant |
US7198680B1 (en) | 2006-07-26 | 2007-04-03 | Innovation Services, Inc. | Process for cleaning surfaces of medical equipment |
US7226897B1 (en) | 2006-07-26 | 2007-06-05 | Innovation Services, Inc. | Water soluble barrier film conformal coating composition |
US7541321B2 (en) | 2006-07-26 | 2009-06-02 | Innovation Services, Inc. | Water soluble barrier film conformal coating composition |
EP2934132B1 (en) * | 2012-12-14 | 2018-07-04 | Saban Ventures Pty Limited | Disinfectant |
CN104041511B (en) * | 2014-06-18 | 2016-06-29 | 海南朗腾医疗设备有限公司 | A kind of solution for haemodialysis control unit sterilization and cleaning and preparation method thereof |
CN109705986A (en) * | 2019-01-25 | 2019-05-03 | 石华英 | A kind of no enzyme multipurpose medical instrument cleaning agent, preparation method and application |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2639233B1 (en) * | 1988-11-23 | 1994-05-06 | Air Liquide | HEMODIALYSIS HYGIENE AGENT |
ES2155824T3 (en) * | 1991-07-15 | 2001-06-01 | Minntech Corp | STERILIZING AGENT OF THE PERACETIC / PEROXIDE, STABLE AND ANTI-CORROSIVE TYPE. |
GB9122048D0 (en) * | 1991-10-17 | 1991-11-27 | Interox Chemicals Ltd | Compositions and uses thereof |
KR0152481B1 (en) * | 1995-06-20 | 1998-11-02 | 김광호 | Remote control system using cordless phone |
TW349994B (en) * | 1996-12-02 | 1999-01-11 | Kao Corp | Surface activator composition |
JP3758417B2 (en) * | 1998-06-02 | 2006-03-22 | ニプロ株式会社 | Dialysis machine cleaning method |
JP2001072996A (en) * | 1999-09-02 | 2001-03-21 | Asahi Denka Kogyo Kk | Bactericidal detergent composition |
TWI243204B (en) * | 2000-02-04 | 2005-11-11 | Sumitomo Chemical Co | Electronic parts cleaning solution |
KR100363896B1 (en) * | 2000-04-21 | 2002-12-16 | 이진식 | A medical instrument cleaning solution using peracetic acid and the manufacturing method of the above solution |
KR100692603B1 (en) * | 2000-06-09 | 2007-03-13 | 애경산업(주) | The aqueous aerosol cleaner composition |
-
2002
- 2002-08-28 KR KR10-2002-0051155A patent/KR100515929B1/en active IP Right Grant
-
2003
- 2003-08-28 AU AU2003253480A patent/AU2003253480A1/en not_active Abandoned
- 2003-08-28 WO PCT/KR2003/001741 patent/WO2004020561A1/en active Search and Examination
- 2003-08-28 CN CNB03824750XA patent/CN1297645C/en not_active Expired - Fee Related
- 2003-08-28 JP JP2004532431A patent/JP2005537355A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1297645C (en) | 2007-01-31 |
AU2003253480A1 (en) | 2004-03-19 |
JP2005537355A (en) | 2005-12-08 |
CN1694949A (en) | 2005-11-09 |
WO2004020561A1 (en) | 2004-03-11 |
KR100515929B1 (en) | 2005-09-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100597092B1 (en) | Aqueous solution of peracetic acid and method for producing the same | |
US20030078178A1 (en) | Low-foaming hydrogen peroxide cleaning solution for organic soils | |
KR100515928B1 (en) | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 1 | |
JP2005154551A (en) | Sterilizing cleanser composition | |
CN111631217A (en) | Low-odor low-corrosivity neutral peroxyacetic acid disinfectant and preparation method thereof | |
WO2007013324A1 (en) | Organic peracid polymer composition and process for producing the same | |
JP2021185211A (en) | Coupling agents for medium-chain fatty acids and disinfecting compositions | |
JP2022520551A (en) | Storage stable antibacterial composition | |
CN113645845B (en) | Improved endoscope disinfectant | |
KR100515929B1 (en) | A composition for disinfecting and washing medical instruments comprising a surfactant having alcohol groups at the both terminals and a process for the preparation thereof 2 | |
JP6835865B2 (en) | Etheramine for improved sporicidal performance | |
JP2002360689A (en) | Cleaning method of artificial dialyzer | |
JP2006206535A (en) | Washing disinfectant for medical equipment | |
JP6444104B2 (en) | Liquid sterilizing detergent composition for washing and method for inactivating non-enveloped viruses in textiles using the same | |
JPH07233396A (en) | Sterilizing detergent for medical equipment | |
JP2838730B2 (en) | Disinfection cleaning agent for medical equipment for artificial dialysis | |
JP2004285154A (en) | Sterilizing cleanser for artificial dialyzer and method for cleansing artificial dialyzer | |
KR102353182B1 (en) | Percitric acid aqueous solution and method for producing the same | |
KR102353181B1 (en) | Peracetic acid aqueous solution and method for producing the same | |
CA2454437A1 (en) | Low-foaming hydrogen peroxide cleaning solution for organic soils | |
WO2021112172A1 (en) | Cleaning agent, and cleaning method and cleaning device using cleaning agent | |
JP2019202976A (en) | Cleaning bactericidal agent composition | |
JP4137432B2 (en) | Disinfectant for medical equipment | |
JP5685497B2 (en) | Disinfectant cleaning composition | |
JP2021176415A (en) | Cleaning method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120628 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20130904 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20140903 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20150910 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20160907 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20170911 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20180904 Year of fee payment: 14 |